BMS-185411 | m-entrepreneurship.com

Product Name :
BMS-185411

Search keywords :
BMS-185411

drugId :
null

Target Vo:
Retinoic acid receptor beta

Target Vo Short Name :
RAR-β

Moa_Name:
Retinoic acid receptor beta agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company Bristol-Myers Squibb Holdings Pharma Ltd Liability Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Skin Diseases

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FGFR1 Antibody
Phospho-Histone H2A.X (Ser139) Antibody (YA190)
JunB Antibody: JunB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 36 kDa, targeting to JunB. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts